Monopar Therapeutics Shares Resume Trade Following Circuit Breaker Halt, Stock Now Up 20%
Portfolio Pulse from Benzinga Newsdesk
Monopar Therapeutics shares resumed trading after a circuit breaker halt, with the stock now up by 20%.
September 25, 2024 | 5:50 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Monopar Therapeutics experienced a significant stock price increase of 20% after trading resumed following a circuit breaker halt.
The 20% increase in Monopar Therapeutics' stock price indicates strong investor interest or positive news. The circuit breaker halt suggests high volatility, but the resumption with a significant price increase is a positive short-term indicator.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100